(firstQuint)A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection.

 This is a randomized, patient, investigator and sponsor blinded, placebo-controlled study in pregnant women with primary HCMV infection.

 The study has three periods: (I) screening (II) double-blinded placebo-controlled treatment and (III) post-delivery follow-up of women and neonates/infants.

 Pregnant women with confirmed primary HCMV infection will participate in periods I and II.

 Mothers and neonates/infants born to mothers enrolled in the study will participate in period III.

.

 A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection@highlight

The purpose of the study is to evaluate the feasibility of using CSJ148 to prevent congenital human cytomegalovirus (HCMV) in pregnant women with primary HCMV infection.

